Shuttle Pharmaceuticals Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Deciphera Pharmaceuticals.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | |
Founding Date | Founding Date 1998 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Waltham, US HQ Lawrence, US |
Employees | Employees 373157% increase | Employees 35037% increase |
Valuation ($) | Valuation ($) 6.4 b | Valuation ($) 2.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $163.4m (FY, 2023) |
Cost of goods | Cost of goods $228.8m (FY, 2025) | Cost of goods $3.7m (FY, 2023) |
Gross profit | Gross profit $1.2b (FY, 2025) | Gross profit $159.6m (FY, 2023) |
Net income | Net income $316.9m (FY, 2025) | Net income ($194.9m) (FY, 2023) |
Operating ⚠ | ||
Patent Applications | Patent Applications 50 (FY, 2020) | Patent Applications 49 (Aug, 2017) |
Patents (US) | Patents (US) 43 (FY, 2020) | Patents (US) 11 (Aug, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 171.9m | Total funding raised $ 714m |
For sources of this data, please see the company profile
View Company Profiles
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company